Friday, July 10, 2026

Drug profile · INN

sarecycline hydrochloride

sarecycline hydrochloride (SEYSARA) is a unknown. Associated with Almirall, S.A.. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sarecycline hydrochloride
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.89

Quick answer

sarecycline hydrochloride (SEYSARA) is a unknown. Associated with Almirall, S.A.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sarecycline hydrochloride
Brand SEYSARA
Mechanism Unknown
Route ORAL
Formulation TABLET
Originator Almirall, S.A.

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is sarecycline hydrochloride?

sarecycline hydrochloride (SEYSARA) is a unknown. Associated with Almirall, S.A.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sarecycline hydrochloride?

SEYSARA is a marketed brand name for sarecycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sarecycline hydrochloride?

sarecycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.